首页 > 最新文献

Pathophysiology最新文献

英文 中文
Comparative Study of Injected Alzheimer's Disease Models in Rats: Insights from Experimental Research. 大鼠注射型阿尔茨海默病模型比较研究:实验研究的启示
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-11-20 DOI: 10.3390/pathophysiology31040047
Hanane Doumar, Hicham El Mostafi, Aboubaker Elhessni, Abderrahim Laaziz, Abdelhalem Mesfioui

Background/objectives: Alzheimer's disease (AD) remains incurable, highlighting the need for new and diverse animal models to better understand its complex mechanisms. This study compares various injected animal models of AD, focusing on the main theories that explain the disease; Methods: Female Wistar rats (10-months old) were administered intracebroventricularly by artificial cerebrospinal fluid (aCSF) (Control), beta amyloid Aβ1-42 (BA), okadaic acid (OKA), lipopolysaccharides (LPS), buthionine sulfoximine (BSO) or by a mixture of these different molecules (MLG). Cognitive performance was assessed one week or one month after stereotaxic surgery; Results: Our results, show that only the Aβ and the MLG induced a persistence and progressive deficits in the working memory, recognition memory and spatial memory in rats. As the hippocampus (HIP) and the prefrontal cortex (PFC) are particularly involved in memory behavior, we analyzed long-term neuroadaptations in these brain subregions using spectrophotometric and histological methods to assess oxidative stress changes and neuronal loss, respectively. We found that the behavioral impairments in memory and learning were accompanied by irreversible oxidative stress changes and neurodegenerescence, particularly in the HIP; Conclusions: This study provides promising data on the modeling of AD in order to develop an effective therapeutic approach.

背景/目的:阿尔茨海默病(AD)仍然无法治愈,因此需要建立新的、多样化的动物模型,以更好地了解其复杂的发病机制。本研究比较了各种注射型阿兹海默症动物模型,重点关注解释该疾病的主要理论; 方法:雌性 Wistar 大鼠(10 个月大对雌性 Wistar 大鼠(10 个月大)进行人工脑脊液 (aCSF) (对照组)、β 淀粉样蛋白 Aβ1-42 (BA)、冈田酸 (OKA)、脂多糖 (LPS)、丁硫亚胺 (BSO) 或这些不同分子的混合物 (MLG) 的静脉注射。在立体定向手术后一周或一个月对认知能力进行评估;结果:我们的研究结果表明,只有 Aβ 和 MLG 会导致大鼠的工作记忆、识别记忆和空间记忆出现持续性和渐进性缺陷。由于海马(HIP)和前额叶皮质(PFC)尤其参与记忆行为,我们采用分光光度法和组织学方法分析了这些大脑亚区的长期神经适应性,分别评估氧化应激变化和神经元损失。我们发现,记忆和学习行为障碍伴随着不可逆的氧化应激变化和神经变性,尤其是在 HIP 中;结论:这项研究提供了有关注意力缺失症建模的可靠数据,有助于开发有效的治疗方法。
{"title":"Comparative Study of Injected Alzheimer's Disease Models in Rats: Insights from Experimental Research.","authors":"Hanane Doumar, Hicham El Mostafi, Aboubaker Elhessni, Abderrahim Laaziz, Abdelhalem Mesfioui","doi":"10.3390/pathophysiology31040047","DOIUrl":"10.3390/pathophysiology31040047","url":null,"abstract":"<p><strong>Background/objectives: </strong>Alzheimer's disease (AD) remains incurable, highlighting the need for new and diverse animal models to better understand its complex mechanisms. This study compares various injected animal models of AD, focusing on the main theories that explain the disease; Methods: Female Wistar rats (10-months old) were administered intracebroventricularly by artificial cerebrospinal fluid (aCSF) (Control), beta amyloid Aβ1-42 (BA), okadaic acid (OKA), lipopolysaccharides (LPS), buthionine sulfoximine (BSO) or by a mixture of these different molecules (MLG). Cognitive performance was assessed one week or one month after stereotaxic surgery; Results: Our results, show that only the Aβ and the MLG induced a persistence and progressive deficits in the working memory, recognition memory and spatial memory in rats. As the hippocampus (HIP) and the prefrontal cortex (PFC) are particularly involved in memory behavior, we analyzed long-term neuroadaptations in these brain subregions using spectrophotometric and histological methods to assess oxidative stress changes and neuronal loss, respectively. We found that the behavioral impairments in memory and learning were accompanied by irreversible oxidative stress changes and neurodegenerescence, particularly in the HIP; Conclusions: This study provides promising data on the modeling of AD in order to develop an effective therapeutic approach.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"643-659"},"PeriodicalIF":2.7,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy-Associated Plasma Protein A (PAPP-A) as a Predictor of Third Trimester Obesity: Insights from the CRIOBES Project. 妊娠相关血浆蛋白 A (PAPP-A) 作为怀孕三个月肥胖的预测因子:CRIOBES 项目的启示。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-11-15 DOI: 10.3390/pathophysiology31040046
Inmaculada Gabaldón-Rodríguez, Carmen de Francisco-Montero, Inmaculada Menéndez-Moreno, Álvaro Balongo-Molina, Ana Isabel Gómez-Lorenzo, Rubén Rodríguez-García, Ángel Vilches-Arenas, Manuel Ortega-Calvo

Introduction: Our objective in this article was to develop a predictive model for obesity in the third trimester of pregnancy using the plasma and clinical biomarkers that are managed within the Chromosomopathies Programme in the Andalusian Public Healthcare System. Methods: The epidemiological design was observational, of the unmatched case-control type. The geographical environment was the Seville Primary Healthcare District (DSAP Sevilla). The information was collected between 2011 and 2021. The reference cohort consisted of women who had carried a pregnancy to term. The variables and biomarkers studied correspond to those managed within the primary-care Pregnancy Integrated Care Pathway (ICP). Unconditional binary logistic regression (BLR) models were created, with the outcome variable being whether or not the women were obese in their third trimester of pregnancy. Results: A total of 423 controls and 104 cases of obesity were obtained for women in their third trimester who had not been obese in their first trimester. The average age for the sample group (P50) was 34 years old. The final, most parsimonious model included the variables PAPP-A (p = 0.074), beta-hCG (p = 0.1631), and systolic blood pressure (SBP) (p = 0.085). ROC curve = 0.75 (C.I. at 95%: 0.63-0.86). Discussion: The results of this research can only be extrapolated to primary care and to pregnancies with no complications. PAPP-A has been shown in our research to be a significant predictor of obesity risk in the third trimester of pregnancies with no complications (OR = 0.53; C.I. at 95%: 0.39-0.66; p = 0.04 in the single-variant study; OR = 0.58; C.I. at 95%: 0.29-0.93; p = 0.074 in the multi-variant analysis). This predictive capacity is further enhanced from an operational perspective by beta-hCG and 12-week SBP.

导言本文的目的是利用安达卢西亚公共医疗系统染色体病项目管理的血浆和临床生物标记物,建立怀孕三个月肥胖症的预测模型。研究方法流行病学设计为观察性的非匹配病例对照类型。地理环境为塞维利亚初级医疗保健区(DSAP Sevilla)。信息收集时间为 2011 年至 2021 年。参照队列由妊娠足月的妇女组成。研究的变量和生物标志物与初级保健妊娠综合护理路径(ICP)中管理的变量和生物标志物一致。我们建立了无条件二元逻辑回归(BLR)模型,结果变量是妇女在怀孕三个月时是否肥胖。结果共获得 423 个对照组和 104 个肥胖病例,均为妊娠三个月且在妊娠头三个月未患肥胖症的妇女。样本组(P50)的平均年龄为 34 岁。最终最合理的模型包括 PAPP-A 变量(p = 0.074)、β-hCG 变量(p = 0.1631)和收缩压(SBP)变量(p = 0.085)。ROC 曲线 = 0.75(C.I. at 95%:0.63-0.86)。讨论这项研究的结果只能用于初级保健和无并发症的妊娠。我们的研究表明,PAPP-A 可显著预测无并发症妊娠第三孕期的肥胖风险(OR = 0.53;C.I. at 95%:0.39-0.66;P.I. at 95%:0.63-0.86):0.39-0.66; p = 0.04; OR = 0.58; C.I. at 95%:多变量分析中,OR = 0.29-0.93; p = 0.074)。从操作角度来看,β-hCG 和 12 周 SBP 进一步增强了这种预测能力。
{"title":"Pregnancy-Associated Plasma Protein A (PAPP-A) as a Predictor of Third Trimester Obesity: Insights from the CRIOBES Project.","authors":"Inmaculada Gabaldón-Rodríguez, Carmen de Francisco-Montero, Inmaculada Menéndez-Moreno, Álvaro Balongo-Molina, Ana Isabel Gómez-Lorenzo, Rubén Rodríguez-García, Ángel Vilches-Arenas, Manuel Ortega-Calvo","doi":"10.3390/pathophysiology31040046","DOIUrl":"10.3390/pathophysiology31040046","url":null,"abstract":"<p><p><b>Introduction:</b> Our objective in this article was to develop a predictive model for obesity in the third trimester of pregnancy using the plasma and clinical biomarkers that are managed within the Chromosomopathies Programme in the Andalusian Public Healthcare System. <b>Methods:</b> The epidemiological design was observational, of the unmatched case-control type. The geographical environment was the Seville Primary Healthcare District (DSAP Sevilla). The information was collected between 2011 and 2021. The reference cohort consisted of women who had carried a pregnancy to term. The variables and biomarkers studied correspond to those managed within the primary-care Pregnancy Integrated Care Pathway (ICP). Unconditional binary logistic regression (BLR) models were created, with the outcome variable being whether or not the women were obese in their third trimester of pregnancy. <b>Results</b>: A total of 423 controls and 104 cases of obesity were obtained for women in their third trimester who had not been obese in their first trimester. The average age for the sample group (P50) was 34 years old. The final, most parsimonious model included the variables PAPP-A (<i>p</i> = 0.074), beta-hCG (<i>p</i> = 0.1631), and systolic blood pressure (SBP) (<i>p</i> = 0.085). ROC curve = 0.75 (C.I. at 95%: 0.63-0.86). <b>Discussion</b>: The results of this research can only be extrapolated to primary care and to pregnancies with no complications. PAPP-A has been shown in our research to be a significant predictor of obesity risk in the third trimester of pregnancies with no complications (OR = 0.53; C.I. at 95%: 0.39-0.66; <i>p</i> = 0.04 in the single-variant study; OR = 0.58; C.I. at 95%: 0.29-0.93; <i>p</i> = 0.074 in the multi-variant analysis). This predictive capacity is further enhanced from an operational perspective by beta-hCG and 12-week SBP.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"631-642"},"PeriodicalIF":2.7,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis. 危重病人的 IGFBP-2:生长激素/类胰岛素生长因子轴的预后标记。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-11-01 DOI: 10.3390/pathophysiology31040045
Christos Savvidis, Eleni Kouroglou, Efthymia Kallistrou, Dimitra Ragia, Sofia Dionysopoulou, Georgios Gavriiloglou, Vasiliki Tsiama, Stella Proikaki, Konstantinos Belis, Ioannis Ilias

Critical illness (CI) triggers complex disruptions in the growth hormone (GH)/insulin-like growth factor (IGF) axis, significantly affecting the dynamics of insulin-like growth-factor-binding proteins (IGFBPs). Among these, IGFBP-2 shows a sustained elevation during CI, which inversely correlates with serum levels of IGF-1, IGFBP-3, and the acid-labile subunit (ALS). Although IGFBP-2 does not directly interact with ALS, it may influence the availability of IGFs by competing with other IGFBPs for binding to IGF-1 and IGF-2. Research suggests that this persistent elevation of IGFBP-2 is largely driven by cytokine activity during CI, reflecting an adaptive response rather than a direct result of GH/IGF axis dysregulation. The clinical importance of IGFBP-2 is emphasized by its correlation with disease severity in conditions like sepsis and coronavirus disease 2019 (COVID-19), where its levels are markedly elevated compared to healthy controls and are similar to those observed in sepsis from various causes. Beyond its role in endocrine regulation, IGFBP-2 appears to play a part in metabolic and inflammatory pathways. Elevated IGFBP-2 levels have been linked to increased mortality and longer hospital stays, indicating its potential utility as a prognostic marker. Furthermore, measuring plasma IGFBP-2 may have other diagnostic applications, aiding in the assessment of CI when traditional biomarkers are inconclusive.

危重病(CI)会引发生长激素(GH)/胰岛素样生长因子(IGF)轴的复杂紊乱,严重影响胰岛素样生长因子结合蛋白(IGFBPs)的动态变化。其中,IGFBP-2 在 CI 期间持续升高,与血清中 IGF-1、IGFBP-3 和耐酸亚基(ALS)的水平成反比。虽然 IGFBP-2 并不直接与 ALS 相互作用,但它可能通过与其他 IGFBPs 竞争结合 IGF-1 和 IGF-2 来影响 IGFs 的可用性。研究表明,IGFBP-2 的持续升高主要是由 CI 期间的细胞因子活动驱动的,反映了一种适应性反应,而不是 GH/IGF 轴失调的直接结果。IGFBP-2与败血症和2019年冠状病毒病(COVID-19)等疾病严重程度的相关性强调了IGFBP-2的临床重要性,在这些疾病中,IGFBP-2的水平与健康对照组相比明显升高,与各种原因引起的败血症中观察到的水平相似。除了在内分泌调节中的作用外,IGFBP-2 似乎还在新陈代谢和炎症途径中发挥作用。IGFBP-2 水平升高与死亡率升高和住院时间延长有关,这表明它作为预后标志物的潜在作用。此外,测量血浆 IGFBP-2 还可能有其他诊断用途,在传统生物标志物无法得出结论的情况下帮助评估 CI。
{"title":"IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis.","authors":"Christos Savvidis, Eleni Kouroglou, Efthymia Kallistrou, Dimitra Ragia, Sofia Dionysopoulou, Georgios Gavriiloglou, Vasiliki Tsiama, Stella Proikaki, Konstantinos Belis, Ioannis Ilias","doi":"10.3390/pathophysiology31040045","DOIUrl":"10.3390/pathophysiology31040045","url":null,"abstract":"<p><p>Critical illness (CI) triggers complex disruptions in the growth hormone (GH)/insulin-like growth factor (IGF) axis, significantly affecting the dynamics of insulin-like growth-factor-binding proteins (IGFBPs). Among these, IGFBP-2 shows a sustained elevation during CI, which inversely correlates with serum levels of IGF-1, IGFBP-3, and the acid-labile subunit (ALS). Although IGFBP-2 does not directly interact with ALS, it may influence the availability of IGFs by competing with other IGFBPs for binding to IGF-1 and IGF-2. Research suggests that this persistent elevation of IGFBP-2 is largely driven by cytokine activity during CI, reflecting an adaptive response rather than a direct result of GH/IGF axis dysregulation. The clinical importance of IGFBP-2 is emphasized by its correlation with disease severity in conditions like sepsis and coronavirus disease 2019 (COVID-19), where its levels are markedly elevated compared to healthy controls and are similar to those observed in sepsis from various causes. Beyond its role in endocrine regulation, IGFBP-2 appears to play a part in metabolic and inflammatory pathways. Elevated IGFBP-2 levels have been linked to increased mortality and longer hospital stays, indicating its potential utility as a prognostic marker. Furthermore, measuring plasma IGFBP-2 may have other diagnostic applications, aiding in the assessment of CI when traditional biomarkers are inconclusive.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"621-630"},"PeriodicalIF":2.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factor V Leiden (R506Q), Prothrombin G20210A, and MTHFR C677T Variants and Thrombophilia in Qatar Biobank Participants: A Case Control Study. 卡塔尔生物库参与者的因子 V Leiden (R506Q)、凝血酶原 G20210A 和 MTHFR C677T 变异与血栓性疾病:病例对照研究。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-10-21 DOI: 10.3390/pathophysiology31040044
Sapha Shibeeb, Nada Al-Rayashi, Nehal Shams, Tameem Hadvan, Ejaife O Agbani, Atiyeh M Abdallah

Background: Thrombophilia, a predisposition to develop blood clots, is very common and can have serious sequelae. Aim: This study aimed to determine the prevalence of three thrombophilia-related genetic variants-factor V Leiden (FVL), prothrombin (F2) G20210A, and MTHFR C677T-in the Qatari population and their associations with self-reported thrombosis. Methods: We analysed samples from 408 Qatari participants [304 controls and 104 with self-reported thrombosis (deep vein thrombosis, pulmonary embolus, or ischaemic stroke)] from the Qatar Biobank. FVL (rs6025), F2 (rs1799963), and MTHFR (rs1801133) variants were genotyped using TaqMan assays. Results: Participants with self-reported thrombosis were older and more likely to be female. FVL A allele carriage (GA + AA vs. GG) was significantly higher in thrombosis cases (OR 3.6, p = 0.0002). In addition, individuals carrying FVL AA and GA genotypes had a lower mean platelet volume on average than those with the GG genotype (p = 0.03). MTHFR C677T did not show a similar association, and the F2 G20210A variant was too rare for analysis. Conclusions: There were significant differences in FVL A allele carriage between individuals with a history of thrombosis and the control group. Future research should explore the complex interplay between genetics and environment in thrombosis risk within this population.

背景:血栓性疾病是一种易患血凝块的疾病,非常常见,并可能产生严重的后遗症。目的:本研究旨在确定三种血栓性疾病相关遗传变异--因子 V Leiden (FVL)、凝血酶原 (F2) G20210A 和 MTHFR C677T--在卡塔尔人口中的患病率及其与自我报告的血栓形成之间的关系。研究方法我们分析了来自卡塔尔生物库的 408 名卡塔尔参与者[304 名对照组和 104 名自述血栓形成(深静脉血栓、肺栓塞或缺血性中风)患者]的样本。使用 TaqMan 检测法对 FVL(rs6025)、F2(rs1799963)和 MTHFR(rs1801133)变异进行了基因分型。结果自我报告血栓形成的参与者年龄较大,且更可能是女性。在血栓病例中,FVL A等位基因携带者(GA + AA 与 GG)明显较多(OR 3.6,p = 0.0002)。此外,FVL AA 和 GA 基因型携带者的平均血小板体积低于 GG 基因型携带者(p = 0.03)。MTHFR C677T 并未显示出类似的关联性,而 F2 G20210A 变异则过于罕见,无法进行分析。结论有血栓形成史的人与对照组之间在FVL A等位基因携带量上存在明显差异。未来的研究应探索遗传和环境在该人群血栓风险中的复杂相互作用。
{"title":"Factor V Leiden (R506Q), Prothrombin G20210A, and MTHFR C677T Variants and Thrombophilia in Qatar Biobank Participants: A Case Control Study.","authors":"Sapha Shibeeb, Nada Al-Rayashi, Nehal Shams, Tameem Hadvan, Ejaife O Agbani, Atiyeh M Abdallah","doi":"10.3390/pathophysiology31040044","DOIUrl":"https://doi.org/10.3390/pathophysiology31040044","url":null,"abstract":"<p><p><b>Background:</b> Thrombophilia, a predisposition to develop blood clots, is very common and can have serious sequelae. <b>Aim:</b> This study aimed to determine the prevalence of three thrombophilia-related genetic variants-factor V Leiden (FVL), prothrombin (F2) G20210A, and MTHFR C677T-in the Qatari population and their associations with self-reported thrombosis. <b>Methods:</b> We analysed samples from 408 Qatari participants [304 controls and 104 with self-reported thrombosis (deep vein thrombosis, pulmonary embolus, or ischaemic stroke)] from the Qatar Biobank. FVL (rs6025), F2 (rs1799963), and MTHFR (rs1801133) variants were genotyped using TaqMan assays. <b>Results:</b> Participants with self-reported thrombosis were older and more likely to be female. FVL A allele carriage (GA + AA vs. GG) was significantly higher in thrombosis cases (OR 3.6, <i>p</i> = 0.0002). In addition, individuals carrying FVL AA and GA genotypes had a lower mean platelet volume on average than those with the GG genotype (<i>p</i> = 0.03). MTHFR C677T did not show a similar association, and the F2 G20210A variant was too rare for analysis. <b>Conclusions:</b> There were significant differences in FVL A allele carriage between individuals with a history of thrombosis and the control group. Future research should explore the complex interplay between genetics and environment in thrombosis risk within this population.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"608-620"},"PeriodicalIF":2.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT. 类黄酮介导的肿瘤血管生成抑制:Ang-Tie/PI3K/AKT的作用
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-10-12 DOI: 10.3390/pathophysiology31040043
Shallu Saini, Hardeep Singh Tuli, Reena V Saini, Adesh K Saini, Katrin Sak, Damandeep Kaur, Moyad Shahwan, Ritu Chauhan, Abhishek Chauhan

Angiogenesis is a process involved in the formation of new blood capillaries from pre-existing ones. It is regulated by several anti-angiogenic molecules involved in tumor growth and metastasis. The endothelial angiopoietin Ang-Tie/PI3K/AKT growth receptor pathway is necessary for healthy vascular development. The activation of AKT is controlled by a multistep process involving phosphoinositide 3-kinase (PI3K). This article aims to provide an overview of the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways and the potential of flavonoids as anti-angiogenic drugs. Flavonoids have shown great potential in preventing angiogenesis by targeting signaling pathways and exhibit additional anti-cancer properties. Research studies have revealed that the currently available anti-angiogenic drugs do not meet the safety and efficacy standards for treating tumor growth. Phytocompounds have long been a valuable resource for the development of novel therapeutic drugs. This article explores recent findings explaining the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways, as well as the interaction of flavonoids with angiogenic signaling pathways as a novel therapeutic approach. Several investigations have shown that synergistic studies of natural phytocompounds have great potential to target these pathways to inhibit tumor growth. Therefore, flavonoid-based medications may offer a more effective synergistic strategy to treat cancer.

血管生成是由原有毛细血管形成新毛细血管的过程。它受到几种参与肿瘤生长和转移的抗血管生成分子的调控。内皮血管生成素 Ang-Tie/PI3K/AKT 生长受体途径是血管健康发育所必需的。AKT 的活化由磷酸肌酸 3- 激酶(PI3K)参与的多步骤过程控制。本文旨在概述 Ang-Tie/PI3K/AKT 信号通路的作用和机制,以及类黄酮作为抗血管生成药物的潜力。黄酮类化合物在通过靶向信号通路防止血管生成方面显示出巨大潜力,并具有其他抗癌特性。研究发现,目前可用的抗血管生成药物在治疗肿瘤生长方面并不符合安全性和有效性标准。植物化合物一直以来都是开发新型治疗药物的宝贵资源。本文探讨了解释 Ang-Tie/PI3K/AKT 信号通路的作用和机制的最新发现,以及黄酮类化合物作为一种新型治疗方法与血管生成信号通路的相互作用。多项研究表明,天然植物化合物的协同研究在针对这些通路抑制肿瘤生长方面具有巨大潜力。因此,基于类黄酮的药物可能为治疗癌症提供更有效的协同策略。
{"title":"Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT.","authors":"Shallu Saini, Hardeep Singh Tuli, Reena V Saini, Adesh K Saini, Katrin Sak, Damandeep Kaur, Moyad Shahwan, Ritu Chauhan, Abhishek Chauhan","doi":"10.3390/pathophysiology31040043","DOIUrl":"https://doi.org/10.3390/pathophysiology31040043","url":null,"abstract":"<p><p>Angiogenesis is a process involved in the formation of new blood capillaries from pre-existing ones. It is regulated by several anti-angiogenic molecules involved in tumor growth and metastasis. The endothelial angiopoietin Ang-Tie/PI3K/AKT growth receptor pathway is necessary for healthy vascular development. The activation of AKT is controlled by a multistep process involving phosphoinositide 3-kinase (PI3K). This article aims to provide an overview of the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways and the potential of flavonoids as anti-angiogenic drugs. Flavonoids have shown great potential in preventing angiogenesis by targeting signaling pathways and exhibit additional anti-cancer properties. Research studies have revealed that the currently available anti-angiogenic drugs do not meet the safety and efficacy standards for treating tumor growth. Phytocompounds have long been a valuable resource for the development of novel therapeutic drugs. This article explores recent findings explaining the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways, as well as the interaction of flavonoids with angiogenic signaling pathways as a novel therapeutic approach. Several investigations have shown that synergistic studies of natural phytocompounds have great potential to target these pathways to inhibit tumor growth. Therefore, flavonoid-based medications may offer a more effective synergistic strategy to treat cancer.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"596-607"},"PeriodicalIF":2.7,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathophysiology and Prevention of Manual-Ventilation-Induced Lung Injury (MVILI). 手动通气诱发肺损伤 (MVILI) 的病理生理学与预防。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-10-12 DOI: 10.3390/pathophysiology31040042
Luke A White, Steven A Conrad, Jonathan Steven Alexander

Manual ventilation, most commonly with a bag-valve mask, is a form of short-term ventilation used during resuscitative efforts in emergent and out-of-hospital scenarios. However, compared to mechanical ventilation, manual ventilation is an operator-dependent skill that is less well controlled and is highly subject to providing inappropriate ventilation to the patient. This article first reviews recent manual ventilation guidelines set forth by the American Heart Association and European Resuscitation Council for providing appropriate manual ventilation parameters (e.g., tidal volume and respiratory rate) in different patient populations in the setting of cardiopulmonary resuscitation. There is then a brief review of clinical and manikin-based studies that demonstrate healthcare providers routinely hyperventilate patients during manual ventilation, particularly in emergent scenarios. A discussion of the possible mechanisms of injury that can occur during inappropriate manual hyperventilation follows, including adverse hemodynamic alterations and lung injury such as acute barotrauma, gastric regurgitation and aspiration, and the possibility of a subacute, inflammatory-driven lung injury. Together, these injurious processes are described as manual-ventilation-induced lung injury (MVILI). This review concludes with a discussion that highlights recent progress in techniques and technologies for minimizing manual hyperventilation and MVILI, with a particular emphasis on tidal-volume feedback devices.

手动通气(最常见的是使用袋阀面罩)是在急救和院外复苏过程中使用的一种短期通气方式。然而,与机械通气相比,手动通气是一种依赖于操作者的技能,其可控性较差,极易为患者提供不适当的通气。本文首先回顾了美国心脏协会和欧洲复苏委员会最近制定的手动通气指南,该指南针对心肺复苏中不同患者群体提供适当的手动通气参数(如潮气量和呼吸频率)。然后简要回顾了临床研究和基于人体模型的研究,这些研究表明医护人员在手动通气过程中经常会对患者过度通气,尤其是在紧急情况下。随后讨论了不当人工过度通气可能导致的损伤机制,包括不良血流动力学改变和肺损伤,如急性气压创伤、胃反流和吸入,以及亚急性炎症性肺损伤的可能性。这些损伤过程统称为人工通气诱发肺损伤(MVILI)。本综述最后讨论了最大限度减少人工过度通气和 MVILI 的技术和工艺的最新进展,并特别强调了潮气量反馈装置。
{"title":"Pathophysiology and Prevention of Manual-Ventilation-Induced Lung Injury (MVILI).","authors":"Luke A White, Steven A Conrad, Jonathan Steven Alexander","doi":"10.3390/pathophysiology31040042","DOIUrl":"https://doi.org/10.3390/pathophysiology31040042","url":null,"abstract":"<p><p>Manual ventilation, most commonly with a bag-valve mask, is a form of short-term ventilation used during resuscitative efforts in emergent and out-of-hospital scenarios. However, compared to mechanical ventilation, manual ventilation is an operator-dependent skill that is less well controlled and is highly subject to providing inappropriate ventilation to the patient. This article first reviews recent manual ventilation guidelines set forth by the American Heart Association and European Resuscitation Council for providing appropriate manual ventilation parameters (e.g., tidal volume and respiratory rate) in different patient populations in the setting of cardiopulmonary resuscitation. There is then a brief review of clinical and manikin-based studies that demonstrate healthcare providers routinely hyperventilate patients during manual ventilation, particularly in emergent scenarios. A discussion of the possible mechanisms of injury that can occur during inappropriate manual hyperventilation follows, including adverse hemodynamic alterations and lung injury such as acute barotrauma, gastric regurgitation and aspiration, and the possibility of a subacute, inflammatory-driven lung injury. Together, these injurious processes are described as manual-ventilation-induced lung injury (MVILI). This review concludes with a discussion that highlights recent progress in techniques and technologies for minimizing manual hyperventilation and MVILI, with a particular emphasis on tidal-volume feedback devices.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"583-595"},"PeriodicalIF":2.7,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model. Empagliflozin 对多囊卵巢综合征的多重益处:来自临床前大鼠模型的证据
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-10-09 DOI: 10.3390/pathophysiology31040041
Dejana Rakic, Vladimir Jakovljevic, Vladimir Zivkovic, Jovana Jakovljevic Uzelac, Nikola Jovic, Maja Muric, Bozidar Pindovic, Aleksandra Dimitrijevic, Petar Arsenijevic, Jovan Rakic, Slobodanka Mitrovic, Tatjana Vulovic, Jovana Joksimovic Jovic

Polycystic ovary syndrome (PCOS) is the most common complex endocrinological condition of women that is associated with infertility and metabolic disorders during the reproductive period. Recently, a great deal of research has focused on the etiopathogenesis of this disorder and the modulation of therapeutic approaches. There are still many controversies in the choice of therapy, and metformin is one of the most commonly used agents in the treatment of PCOS. Considering the link between metabolic disorders and PCOS, glycemic status is crucial in these patients, and sodium-glucose cotransporter type 2 inhibitors (SGLT2is) represent a potentially promising new therapeutic approach. These drugs have been shown to improve glucose metabolism, reduce adipose tissue, decrease oxidative stress, and protect the cardiovascular system. These data prompted us to investigate the effects of empagliflozin (EMPA) in a PCOS rat model and compare them with the effects of metformin. We confirmed that EMPA positively affects somatometric parameters, glucose and lipid metabolism, and the levels of sex hormones, as well as reduces oxidative stress and improves ovarian function and morphology. Administration of EMPA at doses of 5 mg/kg, 15 mg/kg, and 45 mg/kg during a 4-week treatment period improved, as induced by estradiol valerate and a high-fat diet, the metabolic and reproductive statuses in a PCOS rat model. The best effects, which were comparable to the effects of metformin, were achieved in groups receiving the middle and highest applied doses of EMPA. These results may prompt further clinical research on the use of EMPA in patients with PCOS.

多囊卵巢综合征(PCOS)是女性最常见的复杂内分泌疾病,与不孕和生殖期代谢紊乱有关。最近,大量研究都集中在这种疾病的发病机制和治疗方法的调节上。在治疗方法的选择上仍存在许多争议,二甲双胍是治疗多囊卵巢综合征最常用的药物之一。考虑到代谢紊乱与多囊卵巢综合症之间的联系,血糖状况对这些患者至关重要,而钠-葡萄糖共转运体 2 型抑制剂(SGLT2is)是一种有潜力的新治疗方法。这些药物已被证明能改善葡萄糖代谢、减少脂肪组织、降低氧化应激和保护心血管系统。这些数据促使我们对 Empagliflozin(EMPA)在多囊卵巢综合征大鼠模型中的作用进行研究,并将其与二甲双胍的作用进行比较。我们证实,EMPA 对躯体测量参数、葡萄糖和脂质代谢以及性激素水平有积极影响,还能降低氧化应激,改善卵巢功能和形态。在戊酸雌二醇和高脂饮食的诱导下,多囊卵巢综合征大鼠模型的新陈代谢和生殖状况在4周的治疗期内得到了改善,给药剂量分别为5毫克/千克、15毫克/千克和45毫克/千克。接受中等和最高剂量 EMPA 治疗的组取得的效果最好,与二甲双胍的效果相当。这些结果可能会促进对多囊卵巢综合症患者使用 EMPA 的进一步临床研究。
{"title":"Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model.","authors":"Dejana Rakic, Vladimir Jakovljevic, Vladimir Zivkovic, Jovana Jakovljevic Uzelac, Nikola Jovic, Maja Muric, Bozidar Pindovic, Aleksandra Dimitrijevic, Petar Arsenijevic, Jovan Rakic, Slobodanka Mitrovic, Tatjana Vulovic, Jovana Joksimovic Jovic","doi":"10.3390/pathophysiology31040041","DOIUrl":"https://doi.org/10.3390/pathophysiology31040041","url":null,"abstract":"<p><p>Polycystic ovary syndrome (PCOS) is the most common complex endocrinological condition of women that is associated with infertility and metabolic disorders during the reproductive period. Recently, a great deal of research has focused on the etiopathogenesis of this disorder and the modulation of therapeutic approaches. There are still many controversies in the choice of therapy, and metformin is one of the most commonly used agents in the treatment of PCOS. Considering the link between metabolic disorders and PCOS, glycemic status is crucial in these patients, and sodium-glucose cotransporter type 2 inhibitors (SGLT2is) represent a potentially promising new therapeutic approach. These drugs have been shown to improve glucose metabolism, reduce adipose tissue, decrease oxidative stress, and protect the cardiovascular system. These data prompted us to investigate the effects of empagliflozin (EMPA) in a PCOS rat model and compare them with the effects of metformin. We confirmed that EMPA positively affects somatometric parameters, glucose and lipid metabolism, and the levels of sex hormones, as well as reduces oxidative stress and improves ovarian function and morphology. Administration of EMPA at doses of 5 mg/kg, 15 mg/kg, and 45 mg/kg during a 4-week treatment period improved, as induced by estradiol valerate and a high-fat diet, the metabolic and reproductive statuses in a PCOS rat model. The best effects, which were comparable to the effects of metformin, were achieved in groups receiving the middle and highest applied doses of EMPA. These results may prompt further clinical research on the use of EMPA in patients with PCOS.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"559-582"},"PeriodicalIF":2.7,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health. 通往阿尔茨海默病的道路:群集素和载脂蛋白 E 在淀粉样蛋白-β调节和神经元健康中的交叉作用。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-10-02 DOI: 10.3390/pathophysiology31040040
Alexandru Laslo, Laura Laslo, Eliza-Mihaela Arbănași, Alexandru-Andrei Ujlaki-Nagi, Laura Chinezu, Adrian Dumitru Ivănescu, Emil-Marian Arbănași, Roxana Octavia Cărare, Bogdan Andrei Cordoș, Ioana Adriana Popa, Klara Brînzaniuc

One of the hallmarks of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopathy (CAA). Clusterin (CLU), or apolipoprotein J (APOJ), is a multifunctional glycoprotein that has a role in many physiological and neurological conditions, including AD. The apolipoprotein E (APOE) is a significant genetic factor in AD, and while the primary physiological role of APOE in the brain and peripheral tissues is to regulate lipid transport, it also participates in various other biological processes, having three basic human forms: APOE2, APOE3, and APOE4. Notably, the APOE4 allele substantially increases the risk of developing late-onset AD. The main purpose of this review is to examine the roles of CLU and APOE in AD pathogenesis in order to acquire a better understanding of AD pathogenesis from which to develop targeted therapeutic approaches.

阿尔茨海默病(AD)的特征之一是淀粉样蛋白-β(Aβ)以斑块形式沉积在脑细胞外空间和脑血管中,这种情况也被称为脑淀粉样血管病(CAA)。集簇素(CLU)或载脂蛋白 J(APOJ)是一种多功能糖蛋白,在包括注意力缺失症在内的许多生理和神经疾病中发挥作用。载脂蛋白 E(APOE)是导致注意力缺失症的一个重要遗传因素,虽然 APOE 在大脑和外周组织中的主要生理作用是调节脂质转运,但它也参与其他各种生物过程,有三种基本的人类形式:APOE2、APOE3 和 APOE4。值得注意的是,APOE4等位基因会大大增加晚发性AD的发病风险。本综述的主要目的是研究CLU和APOE在AD发病机制中的作用,以便更好地了解AD的发病机制,从而开发有针对性的治疗方法。
{"title":"Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health.","authors":"Alexandru Laslo, Laura Laslo, Eliza-Mihaela Arbănași, Alexandru-Andrei Ujlaki-Nagi, Laura Chinezu, Adrian Dumitru Ivănescu, Emil-Marian Arbănași, Roxana Octavia Cărare, Bogdan Andrei Cordoș, Ioana Adriana Popa, Klara Brînzaniuc","doi":"10.3390/pathophysiology31040040","DOIUrl":"https://doi.org/10.3390/pathophysiology31040040","url":null,"abstract":"<p><p>One of the hallmarks of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopathy (CAA). Clusterin (CLU), or apolipoprotein J (APOJ), is a multifunctional glycoprotein that has a role in many physiological and neurological conditions, including AD. The apolipoprotein E (APOE) is a significant genetic factor in AD, and while the primary physiological role of APOE in the brain and peripheral tissues is to regulate lipid transport, it also participates in various other biological processes, having three basic human forms: APOE2, APOE3, and APOE4. Notably, the APOE4 allele substantially increases the risk of developing late-onset AD. The main purpose of this review is to examine the roles of CLU and APOE in AD pathogenesis in order to acquire a better understanding of AD pathogenesis from which to develop targeted therapeutic approaches.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"545-558"},"PeriodicalIF":2.7,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Radiation-Induced Changes in Lung Tissue and Intercellular Junctions: Implications for Tissue Repair and Fibrosis. 辐射诱发的肺组织和细胞间连接的早期变化:对组织修复和纤维化的影响
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-09-24 DOI: 10.3390/pathophysiology31040039
Ekaterina S Karetnikova, Alexandra A Livanova, Arina A Fedorova, Alexander G Markov

Early changes in lung tissue following ionizing radiation (IR) initiate processes that may lead to either regeneration or fibrosis. Intercellular junction proteins play a crucial role in the organization and function of epithelial tissues, both under normal conditions and after injuries. Alterations in the expression and localization of these proteins can influence the fate of epithelial cells. This study aims to investigate the effects of IR on lung tissue structure, as well as on the levels and distribution of intercellular junction proteins. Wistar rats were subjected to total X-ray irradiation at doses of 2 and 10 Gy. Lung tissue samples were collected for Western blot and histological analysis 72 h post-IR. IR at doses of 2 and 10 Gy led to structural changes in lung tissue and elevated levels of E-cadherin. The 10 Gy IR resulted in increased claudin-4 and occludin in lung parenchyma, decreased claudin-8 and claudin-12 in bronchial epithelium and endothelium, and suppression of apoptosis. Data evaluation indicated that alterations in the protein composition of intercellular junctions are essential processes in lung tissue at early stages after IR, and at least some of these alterations are associated with adaptation.

电离辐射(IR)后肺组织的早期变化启动了可能导致再生或纤维化的过程。细胞间连接蛋白在上皮组织的组织和功能中发挥着至关重要的作用,无论是在正常情况下还是在损伤后都是如此。这些蛋白表达和定位的改变会影响上皮细胞的命运。本研究旨在探讨红外线对肺组织结构以及细胞间连接蛋白水平和分布的影响。对 Wistar 大鼠进行剂量为 2 Gy 和 10 Gy 的全 X 射线照射。收集照射后 72 小时的肺组织样本进行 Western 印迹和组织学分析。2和10 Gy剂量的红外线照射导致肺组织结构发生变化,E-cadherin水平升高。10 Gy IR导致肺实质中的claudin-4和occludin增加,支气管上皮和内皮中的claudin-8和claudin-12减少,并抑制了细胞凋亡。数据评估表明,细胞间连接蛋白质组成的改变是红外线照射后早期肺组织的基本过程,其中至少有一些改变与适应有关。
{"title":"Early Radiation-Induced Changes in Lung Tissue and Intercellular Junctions: Implications for Tissue Repair and Fibrosis.","authors":"Ekaterina S Karetnikova, Alexandra A Livanova, Arina A Fedorova, Alexander G Markov","doi":"10.3390/pathophysiology31040039","DOIUrl":"https://doi.org/10.3390/pathophysiology31040039","url":null,"abstract":"<p><p>Early changes in lung tissue following ionizing radiation (IR) initiate processes that may lead to either regeneration or fibrosis. Intercellular junction proteins play a crucial role in the organization and function of epithelial tissues, both under normal conditions and after injuries. Alterations in the expression and localization of these proteins can influence the fate of epithelial cells. This study aims to investigate the effects of IR on lung tissue structure, as well as on the levels and distribution of intercellular junction proteins. Wistar rats were subjected to total X-ray irradiation at doses of 2 and 10 Gy. Lung tissue samples were collected for Western blot and histological analysis 72 h post-IR. IR at doses of 2 and 10 Gy led to structural changes in lung tissue and elevated levels of E-cadherin. The 10 Gy IR resulted in increased claudin-4 and occludin in lung parenchyma, decreased claudin-8 and claudin-12 in bronchial epithelium and endothelium, and suppression of apoptosis. Data evaluation indicated that alterations in the protein composition of intercellular junctions are essential processes in lung tissue at early stages after IR, and at least some of these alterations are associated with adaptation.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 4","pages":"531-544"},"PeriodicalIF":2.7,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ITIH4 in Rheumatoid Arthritis Pathogenesis: Network Pharmacology and Molecular Docking Analysis Identify CXCR4 as a Potential Receptor. 类风湿性关节炎发病机制中的 ITIH4:网络药理学和分子对接分析确定 CXCR4 为潜在受体。
IF 2.7 Q2 PATHOLOGY Pub Date : 2024-09-20 DOI: 10.3390/pathophysiology31030038
Lovely Joshi, Debolina Chakraborty, Vijay Kumar, Sagarika Biswas

Elevated levels of Inter-alpha-trypsin-inhibitor heavy chain 4 (ITIH4) have grabbed attention in rheumatoid arthritis (RA) pathogenesis, though its precise mechanisms remain unexplored. To elucidate these mechanisms, a comprehensive strategy employing network pharmacology and molecular docking was utilized. RA targets were sourced from the DisGeNET Database while interacting targets of ITIH4 were retrieved from the STRING and Literature databases. Venny 2.1 was used to identify overlapping genes, followed by Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) through Cytoscape 3.10.2 software, and molecular docking was performed in the ClusPro server. The study identified 18 interacting proteins of ITIH4 associated with RA, demonstrating their major involvement in the chemokine signaling pathway by enrichment analysis. Molecular docking of ITIH4 with the 18 proteins revealed that C-X-C chemokine-receptor type 4 (CXCR4), a major protein associated with chemokine signaling, has the highest binding affinity with ITIH4 with energy -1705.7 kcal/mol forming 3 Hydrogen bonds in the active site pocket of ITIH4 with His441, Arg288, Asp443 amino acids. The effect of ITIH4 on CXCR4 was analyzed via knockdown studies in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS), demonstrating the significant downregulation of CXCR4 protein expression validated by Western blot in RA-FLS. In conclusion, it was speculated that CXCR4 might serve as a potential receptor for ITIH4 to activate the chemokine signaling, exacerbating RA pathogenesis.

类风湿关节炎(RA)发病机制中的α-胰蛋白酶间抑制物重链4(ITIH4)水平升高已引起人们的关注,但其确切机制仍未探明。为了阐明这些机制,我们采用了网络药理学和分子对接的综合策略。RA 靶点来自 DisGeNET 数据库,而 ITIH4 的相互作用靶点则来自 STRING 和文献数据库。使用 Venny 2.1 来识别重叠基因,然后通过 Cytoscape 3.10.2 软件识别基因本体(GO)和京都基因组百科全书(KEGG),并在 ClusPro 服务器中进行分子对接。研究发现了18个与RA相关的ITIH4相互作用蛋白,通过富集分析证明了它们在趋化因子信号通路中的主要参与作用。ITIH4 与这 18 个蛋白的分子对接显示,C-X-C 趋化因子受体 4 型(CXCR4)是与趋化因子信号转导相关的主要蛋白,它与 ITIH4 的结合亲和力最高,能量为 -1705.7 kcal/mol,在 ITIH4 的活性位点口袋中与 His441、Arg288、Asp443 氨基酸形成 3 个氢键。通过在类风湿性关节炎成纤维细胞样滑膜细胞(RA-FLS)中进行基因敲除研究,分析了 ITIH4 对 CXCR4 的影响,结果表明在 RA-FLS 中通过 Western 印迹验证了 CXCR4 蛋白表达的显著下调。总之,推测CXCR4可能是ITIH4激活趋化因子信号转导的潜在受体,从而加剧了RA的发病机制。
{"title":"ITIH4 in Rheumatoid Arthritis Pathogenesis: Network Pharmacology and Molecular Docking Analysis Identify CXCR4 as a Potential Receptor.","authors":"Lovely Joshi, Debolina Chakraborty, Vijay Kumar, Sagarika Biswas","doi":"10.3390/pathophysiology31030038","DOIUrl":"10.3390/pathophysiology31030038","url":null,"abstract":"<p><p>Elevated levels of Inter-alpha-trypsin-inhibitor heavy chain 4 (ITIH4) have grabbed attention in rheumatoid arthritis (RA) pathogenesis, though its precise mechanisms remain unexplored. To elucidate these mechanisms, a comprehensive strategy employing network pharmacology and molecular docking was utilized. RA targets were sourced from the DisGeNET Database while interacting targets of ITIH4 were retrieved from the STRING and Literature databases. Venny 2.1 was used to identify overlapping genes, followed by Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) through Cytoscape 3.10.2 software, and molecular docking was performed in the ClusPro server. The study identified 18 interacting proteins of ITIH4 associated with RA, demonstrating their major involvement in the chemokine signaling pathway by enrichment analysis. Molecular docking of ITIH4 with the 18 proteins revealed that C-X-C chemokine-receptor type 4 (CXCR4), a major protein associated with chemokine signaling, has the highest binding affinity with ITIH4 with energy -1705.7 kcal/mol forming 3 Hydrogen bonds in the active site pocket of ITIH4 with His441, Arg288, Asp443 amino acids. The effect of ITIH4 on CXCR4 was analyzed via knockdown studies in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS), demonstrating the significant downregulation of CXCR4 protein expression validated by Western blot in RA-FLS. In conclusion, it was speculated that CXCR4 might serve as a potential receptor for ITIH4 to activate the chemokine signaling, exacerbating RA pathogenesis.</p>","PeriodicalId":19852,"journal":{"name":"Pathophysiology","volume":"31 3","pages":"514-530"},"PeriodicalIF":2.7,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pathophysiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1